India’s Jani Sales has announced it is starting up production on its Baosuo-supplied 80tpd virgin tissue machine, a move which will increase its annual tissue production capacity to +80,000tpy.
TM3 has a design speed of 1,800m/min, and the family-run company made the investment to meet the surge in demand for high-quality, high-softness tissue products across domestic and international markets.
Start-up is on route for May 2026, and PM3 will have a capacity of 80mt per day, adding significantly to Jani Sales’ existing 100mt per day capacity on PM1 (MG Machine) and the 50mt per day on PM2 (Tissue Machine).
Abiali Jani, Managing Director, Jani Sales, told TWM: “Following the successful commissioning of our 50mtd Baosuo line in October 2024, the decision to invest in PM3 – a high-speed, 80mtd line – was a direct response to the accelerated growth we are witnessing in the tissue sector.
“In India, we are seeing a transformative shift in consumer behaviour. Driven by increased hygiene awareness and the rapid expansion of the HoReCa and healthcare sectors, the Indian tissue market is currently outperforming global averages with double-digit growth.
“We aren’t just seeing a demand for more tissue; we are seeing a demand for better tissue.
“Consumers are moving toward premium, softer, and more sustainable products, and PM3 is engineered to deliver exactly that.”
He added that the company’s strategic focus remains dual-track: catering to a burgeoning Pan India market while strengthening its global footprint.
“By utilising Baosuo’s advanced technology, we ensure that our production is not only efficient but also meets the stringent quality standards required for major global destinations.
“PM3 represents our commitment to staying ahead of the curve in a market that is no longer just emerging, but rapidly maturing.”
Jani Sales was established as a trading company for paper and paper board products in 1979 and has grown into a global business with three plants across India. It markets its products in over 10 countries across four continents.
Key market insights
* Domestic Growth: the Indian tissue market is projected to grow at a CAGR of ~12–15% through 2026, fuelled by urbanisation and government-led hygiene initiatives.
* Global Export Strategy: with the global tissue market expected to reach over $100bn by 2026, the PM3’s 1,800m/min speed allows for the economies of scale necessary to compete in high-volume export markets.
* Tissue Trends: A significant trend is the “premiumisation” of the AfH segment and a rising preference for virgin-fibre quality in household products.
